Preclinical Modeling for Therapeutic Development in Cystic Fibrosis

Am J Respir Crit Care Med. 2020 Feb 1;201(3):267-268. doi: 10.1164/rccm.201910-2056ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Cystic Fibrosis*
  • Humans
  • Inflammation
  • Losartan

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Losartan